ストックスクリーナーアプリを入手
7.30
5.82%
0.32
前日終値:
$6.98
開ける：
$6.89
24時間の取引高:
73,896
Relative Volume:
3.43
時価総額：
$6.77M
収益：
$4.03M
当期純損益:
$24.32M
株価収益率:
-1.6974
EPS:
-4.3008
ネットキャッシュフロー:
$-45.76M
1週間 パフォーマンス:
+11.51%
1か月 パフォーマンス:
-25.16%
6か月 パフォーマンス:
-58.27%
1年 パフォーマンス:
-61.46%
1日の値動き範囲:
$6.26
$7.4799
1週間の範囲:
$6.00
$9.255
52週間の値動き範囲:
$6.00
$26.85
Pavmed Inc Stock (PAVM) Company Profile
PAVM を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PAVM
Pavmed Inc
|
7.345 | 6.43M | 4.03M | 24.32M | -45.76M | -4.3008 |
|
ABT
Abbott Laboratories
|
127.09 | 222.19B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.65 | 144.97B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
367.88 | 140.12B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.81 | 128.60B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.86 | 49.82B | 5.88B | 1.34B | 799.60M | 2.3489 |
Pavmed Inc Stock (PAVM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-03-30 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-11-05 | 開始されました | Ascendiant Capital Markets | Buy |
| 2018-06-28 | 開始されました | Maxim Group | Buy |
Pavmed Inc (PAVM) 最新ニュース
PAVmed Announces Reverse Stock Split - citybiz
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 14, 2025 - marketscreener.com
PAVMED announces 1-for-30 reverse stock split - MSN
PAVmed trading halted, news pending - MSN
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
PAVmed stock drops after announcing 1-for-30 reverse split By Investing.com - Investing.com Canada
PAVmed (PAVM) Announces 1-for-30 Reverse Stock Split - GuruFocus
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
PAVmed to implement 1-for-30 reverse stock split in January - Investing.com Nigeria
PAVmed stock drops after announcing 1-for-30 reverse split - Investing.com India
PAVmed to implement 1-for-30 reverse stock split in January By Investing.com - Investing.com South Africa
PAVmed Announces Reverse Stock Split to Maintain Nasdaq Listing - TipRanks
PAVmed announces reverse stock split - marketscreener.com
Why this medical tech company is shrinking its stock 1-for-30 next week - Stock Titan
PAVmed announces reverse stock split to maintain Nasdaq listing - MSN
PAVmed Inc. (NASDAQ:PAVM) Sees Large Drop in Short Interest - Defense World
Here's Why Lucid Diagnostics (LUCD) Declined in Q3 - Finviz
Is PAVmed Inc. stock a buy on dips2025 Technical Overview & Free Fast Gain Swing Trade Alerts - Улправда
Nasdaq Moves: Will PAVmed Inc. stock gain from strong economyEarnings Trend Report & Reliable Price Breakout Alerts - Улправда
Will PAVmed Inc. stock gain from strong economy2025 Price Momentum & Free Low Drawdown Momentum Trade Ideas - Улправда
PAVM FinancialsIncome Statement - Quiver Quantitative
Ascendiant Capital Maintains PAVmed (PAVM) Buy Recommendation - Nasdaq
Ascendiant Capital Lowers Price Target for PAVmed (PAVM) to $17. - GuruFocus
PAVmed stock price target lowered to $17 from $20 at Ascendiant Capital By Investing.com - Investing.com South Africa
PAVmed stock price target lowered to $17 from $20 at Ascendiant Capital - Investing.com
Lucid Diagnostics reports real-world data on esophageal test device By Investing.com - Investing.com Australia
Lucid Diagnostics reports real-world data on esophageal test device - Investing.com
Lucid Diagnostics Announces Positive Data from the Largest Reported Real-World Experience of Esophageal Precancer Detection - PR Newswire
PAVmed approves reverse stock split amendment - MSN
PAVmed Approves Reverse Stock Split Amendment - The Globe and Mail
Lucid Diagnostics Announces $15.3 Million Registered Direct Offe - GuruFocus
Can PAVmed Inc. stock rebound after recent weaknessMarket Growth Report & Daily Market Momentum Tracking - Newser
Is PAVmed Inc. stock cheap compared to fundamentals2025 Short Interest & Capital Efficiency Focused Ideas - Newser
PAVmed (PAVM) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
What drives PAVmed Inc stock priceInflation Impact on Stocks & Control Your Emotions With Discipline Tools - earlytimes.in
Lucid Diagnostics Inc.'s (NASDAQ:LUCD) largest shareholders are individual investors with 38% ownership, public companies own 30% - Yahoo Finance Singapore
Risk Check: Will PAVmed Inc. stock gain from strong economyRecession Risk & Advanced Swing Trade Entry Plans - BỘ NỘI VỤ
Why Being Public Gave PavMed a Competitive Edge - Medical Device and Diagnostic industry
What analysts say about PAVmed Inc stockPrice Channel Trading & Small Investment Capital Tips - earlytimes.in
Pavmed Inc. Reports Q3 2025 Earnings and Strategic Focus - MSN
Will PAVmed Inc. stock benefit from upcoming earnings reports2025 Retail Activity & Low Drawdown Investment Strategies - newser.com
Lucid Diagnostics Named a GenomeWeb 2025 Best Places to Work Top-Ranking Honoree - PR Newswire
Will PAVmed Inc. stock deliver strong dividend growthStop Loss & Weekly Top Stock Performers List - newser.com
GenomeWeb Names Lucid Diagnostics (Nasdaq: LUCD) 2025 Best Places to Work Honoree - Stock Titan
Is PAVmed Inc. stock ready for breakoutPortfolio Gains Report & Community Driven Trade Alerts - newser.com
Is PAVmed Inc. stock cheap at current valuationJuly 2025 Gainers & Consistent Growth Equity Picks - newser.com
Combining machine learning predictions for PAVmed Inc.July 2025 Analyst Calls & Daily Technical Stock Forecast Reports - newser.com
Pavmed Inc (PAVM) 財務データ
収益
当期純利益
現金流量
EPS
1.20%
0.44%
大文字化:
|
ボリューム (24 時間):